• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS INSULIN; IMMUNOREACTIVE INSULIN TEST SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS INSULIN; IMMUNOREACTIVE INSULIN TEST SYSTEM Back to Search Results
Model Number INSULIN
Device Problems Incorrect Measurement (1383); Low Test Results (2458)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 09/28/2022
Event Type  malfunction  
Manufacturer Narrative
The investigation did not identify a product problem.The cause of the event could not be determined.As the roche elecsys results were repeatable, the most likely cause was that the unknown competitor method measures the novorapid insulin (insulin aspart, genetically engineered human insulin analogon) taken by the patient which is not recognized by the elecsys insulin assay.
 
Event Description
The initial reporter received questionable elecsys insulin results for one patient tested on a cobas 8000 e601 module serial number (b)(4).On (b)(6) 2022, the initial insulin result was 0.200 u/ml, and it was accompanied by a data flag.The repeat result was 0.221 u/ml.On (b)(6) 2022, the repeat result performed on a competitor instrument (chemiluminescence instrument) was 118 mu/l.On (b)(6) 2022, the repeated result was performed on the cobas 8000 e601 module and the result was 0.343 u/ml and 0.310 u/ml.On (b)(6) 2022, the repeated result was performed on the cobas 8000 e601 module and the result was 1.15 u/ml, with a dilution ratio of 2:1.The questionable results were reported outside the laboratory.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS INSULIN
Type of Device
IMMUNOREACTIVE INSULIN TEST SYSTEM
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
Manufacturer (Section G)
ROCHE DIAGNOSTICS GMBH
sandhoferstrasse 116
na
mannheim (baden-wurttemberg) 68305
GM   68305
Manufacturer Contact
amy nelson
9115 hague road
na
indianapolis, IN 46250
3174767531
MDR Report Key15668363
MDR Text Key302497186
Report Number1823260-2022-03339
Device Sequence Number1
Product Code CFP
UDI-Device Identifier04015630913060
UDI-Public04015630913060
Combination Product (y/n)N
Reporter Country CodeIT
PMA/PMN Number
K001104
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial
Report Date 10/25/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/25/2022
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date03/31/2023
Device Model NumberINSULIN
Device Catalogue Number12017547122
Device Lot Number58660701
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/30/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
NOVORAPID - ONE UNIT
-
-